A report from TheBusinessResearchCompany shows that the "Global Antivirals Market 2019" is expected to grow to $52.22 billion at a CAGR of 8.2% through 2022. Read more at https://bit.ly/2LfOwpE
The major players covered in the global antivirals market are AbbVie Inc., Bristol-Myers-Squibb, Cipla, F. Hoffmann-La Roche Ltd, Gilead Sciences Inc, GlaxoSmithKline Read More @ https://bit.ly/32SadWe
Major players in the Anti-obesity Drugs Market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Boehringer Ingelheim GmbH, and Pfizer Inc. Read More @ https://bit.ly/3t1IBZj
According to the study, Smallpox – Pipeline Review, H2 2018, researchers are still carrying out studies on smallpox and its treatments. Since smallpox virus is deadly and contagious the research projects are carried out under extreme authorization. The US Centers for Disease Control and Prevention along with the Russian State Centre for Research on Virology and Biotechnology are the only two labs in the world approved and known to have smallpox virus. Recently the US Food and Drug Administration (FDA) approved the first drug to treat smallpox. For more information on the research report, refer to below link https://www.kenresearch.com/healthcare/pharmaceuticals/smallpox-pipeline-review/152640-91.html
Antivirals Global Market Report 2020 is the latest research report added to The Business Research Company database. The report is covered in 200 pages covering 5 major players in the industry.
Liver Cirrhosis is defined as a chronic injury to the liver which results in damage or liver might stop functioning due to chronic consumption of alcohol products, long term liver infection, defects in immune system and obesity etc. Liver cirrhosis develops slowly and it takes many years to develop. The patient with liver cirrhosis disease experience tiredness or unwell, loss of appetite, abdominal pain, white nail, dark urine and disturbed sleep pattern.
Cold sores or oral herpes are small blisters kind abrasions that occur due to the infection caused by the herpes simplex virus (HSV). Cold sores generally occur on the face, around the lips, chin, cheeks and nostrils. They generally cause pain and itching before they burst. HSV is one of the most common viruses found to affect the population and it is endemic throughout the world. Up to 90% of people around the world have at least one form of HSV.
The Hospital Infection Therapeutics Market Size is estimated to reach $14.9 billion by 2027 and is poised to grow at a CAGR of 4.5% over the forecast period of 2022-2027.
Market Size - $1.41 Billion in 2014, Market Growth - CAGR of 5.4%, Market Trends – Increasing consumer preference towards comfortable and high performance apparel
A new research report by Transparency Market Research on the global antiviral drugs market provide all the necessary insights and information required for formulation precise marketing strategies. According to the research report, the global market for antiviral drugs will exhibit a healthy CAGR of 6.40% over the course of the given forecast period of 2016 to 2024. The market is projected to reach a valuation worth US$82.9 bn by the end of the forecast period in 2024.
The report on Antiviral Drugs Market by drug type(drugs and generic drugs), therapeutics(HIV/AIDS therapeutics, hepatitis (B&C) therapeutics, herpes therapeutics, influenza therapeutics and others), end user(hospitals, clinics and ambulatory surgical center) trends analysis and forecasts up to 2023 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Antiviral Drugs Market is projected to grow at a CAGR between 4.0 % to 4.5 % in terms of value over the period of 2017-2023. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.
Anti-Viral Drug Market By Application (HIV Treatment, Hepatitis Treatment, Herpes Treatment, Influenza Treatment, Others) By Type (Generic Drugs, Branded Drugs) By End User (Hospitals, Clinics, Others) and Region - Global Forecast 2016 to 2024.
Hepatitis C is a liver infection caused by the hepatitis C virus (HCV) that results in acute or chronic presentation. The disease is often asymptomatic, but infected patients may experience fatigue, joint pain, itchy skin or jaundice. There is no effective vaccine against HCV, so the market is driven by therapeutics. See Full Report @ bit.ly/ZrFfRz
The global animal model market size was valued at $1.9 billion in 2022 and is projected to reach $3.6 billion by 2032, growing at a CAGR of 6.6% from 2023 to 2032.
According to Straits Research, the global virology market size was valued at USD 2.71 billion in 2023. It is projected to reach from USD 2.84 billion in 2024 to USD 4.20 billion by 2032, growing at a CAGR of 5.05% during the forecast period (2024–2032).https://straitsresearch.com/report/virology-market/request-sample
Global Biosurfactants Market is estimated to reach $2,889 Million by 2024; growing at a CAGR of 4.4% from 2016 to 2024. Biosurfactants are surface-active biomolecule formed by microorganism, frequently used as wetting agents, foaming agents, functional food ingredients, detergents, and much more.
Seaweed farming is considerably expensive than land farming, which could hamper the global seaweed protein market revenue growth. Furthermore, due to presence of harmful minerals, excessive consumption of seaweed might create health concerns.
Paresthesia is a central nervous system (CNS) disorder characterized by an abnormal sensation to the skin such as tickling, tingling, pricking numbness or burning sensation with no apparent physical cause.
According to Straits Research, the global virology market size was valued at USD 2.71 billion in 2023. It is projected to reach from USD 2.84 billion in 2024 to USD 4.20 billion by 2032, growing at a CAGR of 5.05% during the forecast period (2024–2032).https://straitsresearch.com/report/virology-market/request-sample
Purple Foods Market size was estimated at $212 Million in 2020, projected to grow at a CAGR of 3.4% during the forecast period 2021-2026. Purple Foods industry has witnessed huge demand as they are richest source of anthocyanins. Anthocyanins is a form of flavonoid, which is a family of antioxidant chemicals.
The antiviral drug resistance market was valued at US$ 2,572.26 million in 2018 and it is projected to reach US$ 4,573.24 million in 2027; it is expected to grow at a CAGR of 6.8% from 2019 to 2027.
The global uveitis treatment market was worth USD 478 million in 2018 and is expected to reach USD 687 million by 2026, growing at a 4.5% CAGR during 2019-2026.
Global COVID-19 Drug Associated APIs Market by The Business Research Company is segmented as Antimalarials, Bronchodilators, Antibiotics, Antivirals, Others
Rise in the geriatric population, shift toward minimally invasive spine procedures, and surge in prevalence of spine disorders have boosted the growth of the global vertebral compression fracture devices market.
According to the latest research report by IMARC Group, The global medical foods market size reached USD 24.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 37.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.78% during 2025-2033. More Info:- https://www.imarcgroup.com/medical-foods-market
The home infusion therapy market is expected to grow from US$ 21,765.95 million in 2022 to US$ 35,696.05 million by 2028; it is estimated to record a CAGR of 8.6% from 2022 to 2028 Home infusion therapy involves the intravenous or subcutaneous administration of drugs or biologicals to an individual at home. The components needed to perform home infusion include the drug (antivirals, immune globulin), equipment (a pump), and supplies (tubing and catheters).
The Global Antimicrobial & Disinfectant Chemicals Market to witness robust growth at a CAGR of 8.00%over the forecasting phase 2024-2032. Read our latest blog
The algae products market size is projected to reach a valuation of $5.3 billion in 2023 and exceed $7.3 billion by 2028, reflecting a notable compound annual growth rate (CAGR) of 6.4% over the forecast period.
Global STD Diagnostics Market is expected to rise at a CAGR of 18.95% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing prevalence rates of STD.
The Antiviral Coatings Market is growing at a CA GR of 12.5% over the forecasted period 2023 - 2028. Antiviral coatings, also known as antiviral surface treatments or antiviral coatings, are materials applied to surfaces with the aim of reducing or inhibiting the presence and transmission of viruses. These coatings are designed to have antiviral properties, meaning they can inactivate or limit the survival and spread of viruses on treated surfaces. Antiviral coatings are particularly relevant in various settings, such as healthcare facilities, public transportation, and other high-traffic areas, where the risk of viral transmission is a concern.
The global heparin market is anticipated to project growth at a CAGR of 4.01%, during the forecast period, 2024-2032. Get More Insights into our latest blog
The global animal model market was valued at $1,469 million in 2020, and is projected to reach $2,677 million by 2030, registering a CAGR of 6.1% from 2021 to 2030.
The global artificial intelligence (AI) in epidemiology market is set to grow with a 27.33% CAGR between 2024 and 2032. Get more insights into our latest blogs
Viruses are the ultimate parasites as they derive nutrition from the host cell and also hijack and direct its metabolic machinery to synthesize new virus particles. Viruses can live and replicate only inside host body. Anti-viral drugs are specifically used to treat viral infections and act mostly by inhibiting their target viruses. The growth of antiviral drugs market is driven by factors such as rise in healthcare expenditure, growing research and development investment, emergence of virus life-threatening diseases like bird flu, strong development pipeline and increasing incidence rates of viral infections particularly HIV. WHO estimates 36.7 million people are suffering from HIV/AIDS worldwide with 1.1 million deaths of AIDS-related illnesses in 2015.
The global hospital acquired infections therapeutic market size is expected to reach USD 12.52 billion by 2028 according to a new study by Polaris Market Research. The report “Hospital Acquired Infections Therapeutic Market Share, Size, Trends, Industry Analysis Report, By Drug Class (Antibacterial Drugs {Cell Wall Synthesis Inhibitors, Protein Synthesis Inhibitors, Others}, Antiviral Drugs, Antifungal Drugs); By Infection Type; By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
According to the latest research report by IMARC Group, The global medical foods market size reached US$ 23.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 36.5 Billion by 2032, exhibiting a growth rate (CAGR) of 5% during 2024-2032. More Info:- https://www.imarcgroup.com/medical-foods-market
Artificial intelligence (AI) is revolutionizing the fields of animal health market research and veterinary medicine by providing powerful tools for disease diagnosis and treatment.